Targeting the BACE1-GSK-3β Signaling Axis in Alzheimer's Disease: From Molecular Crosstalk to Nanotechnology-Based Translational Strategies.
Molecular neurobiology · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansAmyloid Precursor Protein SecretasesAlzheimer DiseaseGlycogen Synthase Kinase 3 betaAspartic Acid EndopeptidasesAnimalsSignal TransductionNanotechnologyTranslational Research, BiomedicalGlycogen Synthase Kinase 3Alzheimer’s diseaseAmyloid betaDual targetingNanoformulationsTau Hyperphosphorylation
Come citare questo studio
Anitha Marimuthu, Madhu Tanya Singh, Shivaramakrishnan Balasubramanian, Praveen Thaggikuppe Krishnamurthy. (2026). Targeting the BACE1-GSK-3β Signaling Axis in Alzheimer's Disease: From Molecular Crosstalk to Nanotechnology-Based Translational Strategies.. Molecular neurobiology. DOI: 10.1007/s12035-026-06203-1
Consulta la pubblicazione originale ↗